Related Experiment Videos
Terephthalic acid in Sprague-Dawley rats as a hypolipidemic agent
I H Hall1, O T Wong, D J Reynolds
1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27759-7360.
Abstract:
Terephthalic acid at 20 mg/kg/day in lowered serum cholesterol and triglyceride levels in rats. The cholesterol content was lowered in the lipoprotein fractions. The effects of the agents on de novo lipid synthesis showed that similar enzymes were affected in rat liver and small intestinal mucosa cells as when compared to in vitro tissue culture cells from rats and humans, e.g. reduction of acyl CoA cholesterol acyl transferase and elevation of neutral cholesterol ester hydrolase activities suggest that net cholesterol esters deposition in foam cells should be reduced and plaque growth should be slowed. The suppression of LDL receptor binding and degradation by the drug suggest that less apoB lipoproteins are taken up by peripheral tissues. The elevated HDL receptor binding and internalization in the liver suggest that the drug accelerates cholesterol return to the liver. Additional studies show that cholesterol and bile acid secretion in the bile is elevated. However, the bile acids secreted are not lithogenic. Acute toxicity studies show that the agent appears to be safe in rodents. Two observations of increased serum alkaline phosphatase levels and increased liver vacuolation suggest some alteration of hepatic cell morphology, which requires further investigation.
Insights
Terephthalic acid effectively lowers cholesterol and triglycerides in rats by altering lipid synthesis and improving cholesterol transport. Further research is needed to investigate potential liver cell morphology changes observed.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Research
Background:
- Elevated cholesterol and triglyceride levels are significant risk factors for cardiovascular disease.
- Understanding the mechanisms of lipid metabolism is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the effects of terephthalic acid on serum lipid levels and related metabolic pathways in rats.
- To explore the potential of terephthalic acid as a therapeutic agent for dyslipidemia.
Main Methods:
- Administration of terephthalic acid (20 mg/kg/day) to rats.
- Analysis of serum lipid profiles, lipoprotein fractions, and key enzymes involved in lipid synthesis.
- Evaluation of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptor activity.
- Assessment of cholesterol and bile acid secretion in bile.
- Acute toxicity studies in rodents.
Main Results:
- Terephthalic acid significantly reduced serum cholesterol and triglyceride levels.
- Lipid-lowering effects were associated with altered activities of enzymes like acyl CoA cholesterol acyl transferase and neutral cholesterol ester hydrolase.
- The agent modulated LDL and HDL receptor dynamics, promoting cholesterol return to the liver.
- Increased secretion of non-lithogenic bile acids was observed.
- Acute toxicity studies indicated the agent's safety in rodents, though minor liver alterations warrant further investigation.
Conclusions:
- Terephthalic acid demonstrates significant lipid-lowering potential by influencing de novo lipid synthesis and cholesterol transport mechanisms.
- The observed effects suggest a potential role in reducing atherosclerotic plaque progression.
- Further studies are necessary to fully elucidate the implications of observed hepatic cell morphology changes.